Toxigenic E.coli infection is one of the most common causes of childhood diarrhea in developing countries, where it is often accompanied by fatal dehydration, as well as the most common cause of traveler's diarrhea in adults. The heat-stable enterotoxin of E. coli (STa), a small cysteine- rich peptide, triggers fluid and electrolyte secretion by stimulating cyclic GMP. Molecular cloning studies by other investigators have shown that intestinal membrane-bound guanylate cyclase serves as a receptor for STa. Nevertheless, the domain(s) of the receptor important for toxin binding remain unknown. In addition, recent work by the author and collaborators has shown that the toxic actions of STa are enhanced by agents which activate protein kinase C (PKC), including phorbol esters and humoral agents able to activate PKC (carbachol, histamine). The interaction between PKC activators and STa can be observed in intact cells, broken cells, and in membranes treated with highly purified PKC and can be observed as an increase in cyclic GMP production and, in intact cell monolayers, as a marked synergistic chloride secretory response. The implications of these findings are that host susceptibility to the toxin may be modulated by neurohumoral signals in the host. The broad, long-term goals of this project are to understand the nature and function of the STa receptor/guanylate cyclase, and how the cGMP interacts with other signalling systems, especially PKC, in intestinal secretion.
Specific aims i nclude: (l) to determine the STa-binding domain or domains on the extracellular portion of intestinal gnanylate cyclase by using biochemical, immunologic, and site-directed mutagenic approaches; and (2) to determine whether the effects of PKC are, as we hypothesize, due to direct phosphorylation of guanylate cyclase, and if so to determine the site(s) of phosphorylation by phosphopeptide mapping and site-directed mutagenesis. The only modern therapeutic advance in the treatment of diarrhea, oral rehydration therapy, was introduced more than twenty years ago following the discovery of glucose-sodium cotransport in basic investigations. A rededication to understanding basic biochemical mechanisms controlling intestinal secretion and cell signalling may yield the clues needed for future advances in therapy which are so widely needed. Just as cholera toxin and pertussis toxin played key roles in elucidating the structure and function of G-proteins and adenylate cyclase the unusual, hormone-like toxin STa will likely lead to new understanding of intestinal guanylate cyclase and its regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DK049410-05
Application #
2701160
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Hamilton, Frank A
Project Start
1994-05-17
Project End
2000-04-30
Budget Start
1998-05-01
Budget End
2000-04-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Crane, J K (2000) Redistribution of cyclic GMP in response to sodium butyrate in colon cells. Arch Biochem Biophys 376:163-70
Crane, J K (1999) Preformed bacterial toxins. Clin Lab Med 19:583-99
Crane, J K; Majumdar, S; Pickhardt 3rd, D F (1999) Host cell death due to enteropathogenic Escherichia coli has features of apoptosis. Infect Immun 67:2575-84
Crane, J K; Oh, J S (1997) Activation of host cell protein kinase C by enteropathogenic Escherichia coli. Infect Immun 65:3277-85
Crane, J K; Shanks, K L (1996) Phosphorylation and activation of the intestinal guanylyl cyclase receptor for Escherichia coli heat-stable toxin by protein kinase C. Mol Cell Biochem 165:111-20